BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38262237)

  • 21. Geographic Access to High-Volume Care Providers and Survival in Patients with Bone Sarcomas: Nationwide Patterns in the United States.
    Fujiwara T; Ogura K; Alaqeel M; Healey JH
    J Bone Joint Surg Am; 2022 Aug; 104(16):1426-1437. PubMed ID: 35730765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Going the Extra Mile: Improved Survival for Pancreatic Cancer Patients Traveling to High-volume Centers.
    Lidsky ME; Sun Z; Nussbaum DP; Adam MA; Speicher PJ; Blazer DG
    Ann Surg; 2017 Aug; 266(2):333-338. PubMed ID: 27429020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variations in Travel Patterns Affect Regionalization of Complex Cancer Surgery in California.
    Munir MM; Endo Y; Woldesenbet S; Beane J; Dillhoff M; Ejaz A; Cloyd J; Pawlik TM
    Ann Surg Oncol; 2023 Dec; 30(13):8044-8053. PubMed ID: 37659977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of hospital surgical volume on complete gross resection (CGR) rates following primary debulking surgery for advanced stage epithelial ovarian carcinoma.
    Nasioudis D; Kahn R; Chapman-Davis E; Frey MK; Caputo TA; Witkin SS; Holcomb K
    Gynecol Oncol; 2019 Aug; 154(2):401-404. PubMed ID: 31160074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Community Privilege on Access to Care Among Patients Following Complex Cancer Surgery.
    Munir MM; Endo Y; Alaimo L; Moazzam Z; Lima HA; Woldesenbet S; Azap L; Beane J; Kim A; Dillhoff M; Cloyd J; Ejaz A; Pawlik TM
    Ann Surg; 2023 Dec; 278(6):e1250-e1258. PubMed ID: 37436887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Travel Patterns among Patients Undergoing Hepatic Resection in California: Does Driving Further for Care Improve Outcomes?
    Diaz A; Cloyd JM; Manilchuk A; Dillhoff M; Beane J; Tsung A; Ejaz A; Pawlik TM
    J Gastrointest Surg; 2021 Jun; 25(6):1471-1478. PubMed ID: 32514651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disparity of Colon Cancer Outcomes in Rural America: Making the Case to Travel the Extra Mile.
    Raman V; Adam MA; Turner MC; Moore HG; Mantyh CR; Migaly J
    J Gastrointest Surg; 2019 Nov; 23(11):2285-2293. PubMed ID: 31152346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Geriatric co-management leads to safely performed cytoreductive surgery in older women with advanced stage ovarian cancer treated at a tertiary care cancer center.
    Filippova OT; Chi DS; Long Roche K; Sonoda Y; Zivanovic O; Gardner GJ; Tew WP; O'Cearbhaill R; Sarraf S; Sun SW; Alexander K; Korc-Grodzicki B; Shahrokni A
    Gynecol Oncol; 2019 Jul; 154(1):77-82. PubMed ID: 31078241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advanced low grade serous ovarian cancer: A retrospective analysis of surgical and chemotherapeutic management in two high volume oncological centers.
    Di Lorenzo P; Conteduca V; Scarpi E; Adorni M; Multinu F; Garbi A; Betella I; Grassi T; Bianchi T; Di Martino G; Amadori A; Maniglio P; Strada I; Carinelli S; Jaconi M; Aletti G; Zanagnolo V; Maggioni A; Savelli L; De Giorgi U; Landoni F; Colombo N; Fruscio R
    Front Oncol; 2022; 12():970918. PubMed ID: 36237308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overcoming a travel burden to high-volume centers for treatment of retroperitoneal sarcomas is associated with improved survival.
    Schmitz R; Adam MA; Blazer DG
    World J Surg Oncol; 2019 Nov; 17(1):180. PubMed ID: 31684956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. At What Cost to Clinical Trial Enrollment? A Retrospective Study of Patient Travel Burden in Cancer Clinical Trials.
    Borno HT; Zhang L; Siegel A; Chang E; Ryan CJ
    Oncologist; 2018 Oct; 23(10):1242-1249. PubMed ID: 29700209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can regionalization decrease the number of deaths for children who undergo cardiac surgery? A theoretical analysis.
    Chang RK; Klitzner TS
    Pediatrics; 2002 Feb; 109(2):173-81. PubMed ID: 11826192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Soft Tissue Sarcoma of the Extremities: What Is the Value of Treating at High-volume Centers?
    Lazarides AL; Kerr DL; Nussbaum DP; Kreulen RT; Somarelli JA; Blazer DG; Brigman BE; Eward WC
    Clin Orthop Relat Res; 2019 Apr; 477(4):718-727. PubMed ID: 30485258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of travel distance on quality outcomes in colorectal cancer.
    Spaulding AC; Borkar S; Osagiede O; Cochuyt JJ; Lemini R; Otto N; Colibaseanu DT
    Am J Manag Care; 2020 Nov; 26(11):e347-e354. PubMed ID: 33196285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and Validation of 18F-FDG PET/CT-Based Models for Predicting Successful Complete Cytoreduction During Primary Cytoreductive Surgery for Advanced Ovarian cancer.
    Kim J; Gil J; Kim SI; Hwangbo S; Noh JJ; Lee JW; Cheon GJ; Kim JW; Cho YS; Lee M
    Clin Nucl Med; 2023 Feb; 48(2):e51-e59. PubMed ID: 36607373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary surgical cytoreduction in advanced ovarian cancer: An outcome analysis within the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) Group.
    Greggi S; Falcone F; Carputo R; Raspagliesi F; Scaffa C; Laurelli G; Giorda G; Di Vagno G; Petruzzelli F; Cormio G; Marinaccio M; Pignata S
    Gynecol Oncol; 2016 Mar; 140(3):425-9. PubMed ID: 26825616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Greater travel distance to specialized facilities is associated with higher survival for patients with soft-tissue sarcoma: US nationwide patterns.
    Fujiwara T; Ogura K; Healey J
    PLoS One; 2021; 16(6):e0252381. PubMed ID: 34086725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Travel distance and its interaction with patient and hospital factors in pancreas cancer care.
    Siegel J; Engelhardt KE; Hornor MA; Morgan KA; Lancaster WP
    Am J Surg; 2021 Apr; 221(4):819-825. PubMed ID: 32891396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secondary Cytoreduction in Platinum-Resistant Recurrent Ovarian Cancer: A Single-Institution Experience.
    Musella A; Marchetti C; Palaia I; Perniola G; Giorgini M; Lecce F; Vertechy L; Iadarola R; De Felice F; Monti M; Muzii L; Angioli R; Panici PB
    Ann Surg Oncol; 2015 Dec; 22(13):4211-6. PubMed ID: 25801357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regionalization of care for women with ovarian cancer.
    Wright JD; Chen L; Buskwofie A; Tergas AI; St Clair CM; Hou JY; Khoury-Collado F; Ananth CV; Hur C; Neugut AI; Hershman DL
    Gynecol Oncol; 2019 Aug; 154(2):394-400. PubMed ID: 31171408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.